世界の抗体薬物複合体市場2020年:製造業者別、地域別、種類・用途別

【英語タイトル】Global Antibody Drug Conjugate Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20DC0530)・商品コード:GIR20DC0530
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年12月
・ページ数:107
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2~3日)
・調査対象地域:グローバル
・産業分野:医薬品、医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥396,720見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥595,080見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥793,440見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、抗体薬物複合体の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗体薬物複合体の種類別市場規模(アドセトリス、カドサイラ、その他)、用途別市場規模(病院、製薬産業、研究機関)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Seattle Genetics/Takeda、Bayer HealthCare、Immunomedics、Roche、Millennium Pharmaceuticals、ImmunoGen、Heidelberg Pharma、Celldex Therapeutics、Pfizer、Mersana Therapeutics、Oxford BioTherapeutics、Takeda Pharmaceutical Company Limited、
・地域別グローバル市場分析 2015年-2020年
・抗体薬物複合体の北米市場(アメリカ、カナダ、メキシコ)
・抗体薬物複合体のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・抗体薬物複合体のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・抗体薬物複合体の南米市場(ブラジル、アルゼンチン)
・抗体薬物複合体の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:アドセトリス、カドサイラ、その他
・用途別分析:病院、製薬産業、研究機関
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The global Antibody Drug Conjugate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.0% in the forecast period of 2020 to 2025 and will expected to reach USD 2288.6 million by 2025, from USD 1746 million in 2019.

The Antibody Drug Conjugate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Antibody Drug Conjugate market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Antibody Drug Conjugate market has been segmented into
Adcetris
Kadcyl
Other

By Application, Antibody Drug Conjugate has been segmented into:
Hospital
Pharmaceutical Company
Research Institutions

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antibody Drug Conjugate market presented in the report. This section sheds light on the sales growth of different regional and country-level Antibody Drug Conjugate markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antibody Drug Conjugate market.

The report offers in-depth assessment of the growth and other aspects of the Antibody Drug Conjugate market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Antibody Drug Conjugate Market Share Analysis
Antibody Drug Conjugate competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antibody Drug Conjugate sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antibody Drug Conjugate sales, revenue and market share for each player covered in this report.

The major players covered in Antibody Drug Conjugate are:
Seattle Genetics/Takeda
Bayer HealthCare
Immunomedics
Roche
Millennium Pharmaceuticals
ImmunoGen
Heidelberg Pharma
Celldex Therapeutics
Pfizer
Mersana Therapeutics
Oxford BioTherapeutics
Takeda Pharmaceutical Company Limited

Among other players domestic and global, Antibody Drug Conjugate market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibody Drug Conjugate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antibody Drug Conjugate, with price, sales, revenue and global market share of Antibody Drug Conjugate in 2018 and 2019.
Chapter 3, the Antibody Drug Conjugate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibody Drug Conjugate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Antibody Drug Conjugate market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Antibody Drug Conjugate sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Antibody Drug Conjugate Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antibody Drug Conjugate Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Adcetris
1.2.3 Kadcyl
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Antibody Drug Conjugate Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Pharmaceutical Company
1.3.4 Research Institutions
1.4 Overview of Global Antibody Drug Conjugate Market
1.4.1 Global Antibody Drug Conjugate Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Seattle Genetics/Takeda
2.1.1 Seattle Genetics/Takeda Details
2.1.2 Seattle Genetics/Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Seattle Genetics/Takeda SWOT Analysis
2.1.4 Seattle Genetics/Takeda Product and Services
2.1.5 Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bayer HealthCare
2.2.1 Bayer HealthCare Details
2.2.2 Bayer HealthCare Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bayer HealthCare SWOT Analysis
2.2.4 Bayer HealthCare Product and Services
2.2.5 Bayer HealthCare Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Immunomedics
2.3.1 Immunomedics Details
2.3.2 Immunomedics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Immunomedics SWOT Analysis
2.3.4 Immunomedics Product and Services
2.3.5 Immunomedics Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Millennium Pharmaceuticals
2.5.1 Millennium Pharmaceuticals Details
2.5.2 Millennium Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Millennium Pharmaceuticals SWOT Analysis
2.5.4 Millennium Pharmaceuticals Product and Services
2.5.5 Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 ImmunoGen
2.6.1 ImmunoGen Details
2.6.2 ImmunoGen Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 ImmunoGen SWOT Analysis
2.6.4 ImmunoGen Product and Services
2.6.5 ImmunoGen Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Heidelberg Pharma
2.7.1 Heidelberg Pharma Details
2.7.2 Heidelberg Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Heidelberg Pharma SWOT Analysis
2.7.4 Heidelberg Pharma Product and Services
2.7.5 Heidelberg Pharma Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Celldex Therapeutics
2.8.1 Celldex Therapeutics Details
2.8.2 Celldex Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Celldex Therapeutics SWOT Analysis
2.8.4 Celldex Therapeutics Product and Services
2.8.5 Celldex Therapeutics Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer SWOT Analysis
2.9.4 Pfizer Product and Services
2.9.5 Pfizer Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Mersana Therapeutics
2.10.1 Mersana Therapeutics Details
2.10.2 Mersana Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Mersana Therapeutics SWOT Analysis
2.10.4 Mersana Therapeutics Product and Services
2.10.5 Mersana Therapeutics Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Oxford BioTherapeutics
2.11.1 Oxford BioTherapeutics Details
2.11.2 Oxford BioTherapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Oxford BioTherapeutics SWOT Analysis
2.11.4 Oxford BioTherapeutics Product and Services
2.11.5 Oxford BioTherapeutics Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Takeda Pharmaceutical Company Limited
2.12.1 Takeda Pharmaceutical Company Limited Details
2.12.2 Takeda Pharmaceutical Company Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Takeda Pharmaceutical Company Limited SWOT Analysis
2.12.4 Takeda Pharmaceutical Company Limited Product and Services
2.12.5 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Antibody Drug Conjugate Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Antibody Drug Conjugate Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Antibody Drug Conjugate Manufacturer Market Share in 2019
3.3.2 Top 6 Antibody Drug Conjugate Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Antibody Drug Conjugate Sales, Revenue and Market Share by Regions
4.1.1 Global Antibody Drug Conjugate Sales and Market Share by Regions (2015-2020)
4.1.2 Global Antibody Drug Conjugate Revenue and Market Share by Regions (2015-2020)
4.2 North America Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
4.3 Europe Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
4.5 South America Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Antibody Drug Conjugate Sales, Revenue and Market Share by Country
5.1.1 North America Antibody Drug Conjugate Sales and Market Share by Country (2015-2020)
5.1.2 North America Antibody Drug Conjugate Revenue and Market Share by Country (2015-2020)
5.2 United States Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
5.3 Canada Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
5.4 Mexico Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Antibody Drug Conjugate Sales, Revenue and Market Share by Country
6.1.1 Europe Antibody Drug Conjugate Sales and Market Share by Country (2015-2020)
6.1.2 Europe Antibody Drug Conjugate Revenue and Market Share by Country (2015-2020)
6.2 Germany Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
6.3 UK Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
6.4 France Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
6.5 Russia Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
6.6 Italy Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Antibody Drug Conjugate Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Antibody Drug Conjugate Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Antibody Drug Conjugate Revenue and Market Share by Regions (2015-2020)
7.2 China Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
7.3 Japan Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
7.4 Korea Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
7.5 India Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
7.7 Australia Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Antibody Drug Conjugate Sales, Revenue and Market Share by Country
8.1.1 South America Antibody Drug Conjugate Sales and Market Share by Country (2015-2020)
8.1.2 South America Antibody Drug Conjugate Revenue and Market Share by Country (2015-2020)
8.2 Brazil Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
8.3 Argentina Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Antibody Drug Conjugate Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Antibody Drug Conjugate Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Antibody Drug Conjugate Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
9.3 Turkey Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
9.4 Egypt Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
9.5 South Africa Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Antibody Drug Conjugate Sales and Market Share by Type (2015-2020)
10.2 Global Antibody Drug Conjugate Revenue and Market Share by Type (2015-2020)
10.3 Global Antibody Drug Conjugate Price by Type (2015-2020)
11 Global Antibody Drug Conjugate Market Segment by Application
11.1 Global Antibody Drug Conjugate Sales Market Share by Application (2015-2020)
11.2 Global Antibody Drug Conjugate Revenue Market Share by Application (2015-2020)
11.3 Global Antibody Drug Conjugate Price by Application (2015-2020)
12 Market Forecast
12.1 Global Antibody Drug Conjugate Sales, Revenue and Growth Rate (2021-2025)
12.2 Antibody Drug Conjugate Market Forecast by Regions (2021-2025)
12.2.1 North America Antibody Drug Conjugate Market Forecast (2021-2025)
12.2.2 Europe Antibody Drug Conjugate Market Forecast (2021-2025)
12.2.3 Asia-Pacific Antibody Drug Conjugate Market Forecast (2021-2025)
12.2.4 South America Antibody Drug Conjugate Market Forecast (2021-2025)
12.2.5 Middle East & Africa Antibody Drug Conjugate Market Forecast (2021-2025)
12.3 Antibody Drug Conjugate Market Forecast by Type (2021-2025)
12.3.1 Global Antibody Drug Conjugate Sales Forecast by Type (2021-2025)
12.3.2 Global Antibody Drug Conjugate Market Share Forecast by Type (2021-2025)
12.4 Antibody Drug Conjugate Market Forecast by Application (2021-2025)
12.4.1 Global Antibody Drug Conjugate Sales Forecast by Application (2021-2025)
12.4.2 Global Antibody Drug Conjugate Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Antibody Drug Conjugate Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Antibody Drug Conjugate by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Antibody Drug Conjugate Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Seattle Genetics/Takeda Basic Information, Manufacturing Base and Competitors
Table 8. Seattle Genetics/Takeda Antibody Drug Conjugate Major Business
Table 9. Seattle Genetics/Takeda Antibody Drug Conjugate Total Revenue (USD Million) (2017-2018)
Table 10. Seattle Genetics/Takeda SWOT Analysis
Table 11. Seattle Genetics/Takeda Antibody Drug Conjugate Product and Services
Table 12. Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bayer HealthCare Basic Information, Manufacturing Base and Competitors
Table 14. Bayer HealthCare Antibody Drug Conjugate Major Business
Table 15. Bayer HealthCare Antibody Drug Conjugate Total Revenue (USD Million) (2017-2018)
Table 16. Bayer HealthCare SWOT Analysis
Table 17. Bayer HealthCare Antibody Drug Conjugate Product and Services
Table 18. Bayer HealthCare Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Immunomedics Basic Information, Manufacturing Base and Competitors
Table 20. Immunomedics Antibody Drug Conjugate Major Business
Table 21. Immunomedics Antibody Drug Conjugate Total Revenue (USD Million) (2017-2018)
Table 22. Immunomedics SWOT Analysis
Table 23. Immunomedics Antibody Drug Conjugate Product and Services
Table 24. Immunomedics Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Roche Basic Information, Manufacturing Base and Competitors
Table 26. Roche Antibody Drug Conjugate Major Business
Table 27. Roche Antibody Drug Conjugate Total Revenue (USD Million) (2017-2018)
Table 28. Roche SWOT Analysis
Table 29. Roche Antibody Drug Conjugate Product and Services
Table 30. Roche Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Millennium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Millennium Pharmaceuticals Antibody Drug Conjugate Major Business
Table 33. Millennium Pharmaceuticals Antibody Drug Conjugate Total Revenue (USD Million) (2017-2018)
Table 34. Millennium Pharmaceuticals SWOT Analysis
Table 35. Millennium Pharmaceuticals Antibody Drug Conjugate Product and Services
Table 36. Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. ImmunoGen Basic Information, Manufacturing Base and Competitors
Table 38. ImmunoGen Antibody Drug Conjugate Major Business
Table 39. ImmunoGen Antibody Drug Conjugate Total Revenue (USD Million) (2017-2018)
Table 40. ImmunoGen SWOT Analysis
Table 41. ImmunoGen Antibody Drug Conjugate Product and Services
Table 42. ImmunoGen Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Heidelberg Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Heidelberg Pharma Antibody Drug Conjugate Major Business
Table 45. Heidelberg Pharma Antibody Drug Conjugate Total Revenue (USD Million) (2017-2018)
Table 46. Heidelberg Pharma SWOT Analysis
Table 47. Heidelberg Pharma Antibody Drug Conjugate Product and Services
Table 48. Heidelberg Pharma Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Celldex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 50. Celldex Therapeutics Antibody Drug Conjugate Major Business
Table 51. Celldex Therapeutics Antibody Drug Conjugate Total Revenue (USD Million) (2017-2018)
Table 52. Celldex Therapeutics SWOT Analysis
Table 53. Celldex Therapeutics Antibody Drug Conjugate Product and Services
Table 54. Celldex Therapeutics Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Pfizer Basic Information, Manufacturing Base and Competitors
Table 56. Pfizer Antibody Drug Conjugate Major Business
Table 57. Pfizer Antibody Drug Conjugate Total Revenue (USD Million) (2017-2018)
Table 58. Pfizer SWOT Analysis
Table 59. Pfizer Antibody Drug Conjugate Product and Services
Table 60. Pfizer Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Mersana Therapeutics Basic Information, Manufacturing Base and Competitors
Table 62. Mersana Therapeutics Antibody Drug Conjugate Major Business
Table 63. Mersana Therapeutics Antibody Drug Conjugate Total Revenue (USD Million) (2017-2018)
Table 64. Mersana Therapeutics SWOT Analysis
Table 65. Mersana Therapeutics Antibody Drug Conjugate Product and Services
Table 66. Mersana Therapeutics Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Oxford BioTherapeutics Basic Information, Manufacturing Base and Competitors
Table 68. Oxford BioTherapeutics Antibody Drug Conjugate Major Business
Table 69. Oxford BioTherapeutics Antibody Drug Conjugate Total Revenue (USD Million) (2017-2018)
Table 70. Oxford BioTherapeutics SWOT Analysis
Table 71. Oxford BioTherapeutics Antibody Drug Conjugate Product and Services
Table 72. Oxford BioTherapeutics Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base and Competitors
Table 74. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Major Business
Table 75. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Total Revenue (USD Million) (2017-2018)
Table 76. Takeda Pharmaceutical Company Limited SWOT Analysis
Table 77. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product and Services
Table 78. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Antibody Drug Conjugate Sales by Manufacturer (2018-2019) (K Units)
Table 80. Global Antibody Drug Conjugate Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Antibody Drug Conjugate Sales by Regions (2015-2020) (K Units)
Table 82. Global Antibody Drug Conjugate Sales Market Share by Regions (2015-2020)
Table 83. Global Antibody Drug Conjugate Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Antibody Drug Conjugate Sales by Countries (2015-2020) (K Units)
Table 85. North America Antibody Drug Conjugate Sales Market Share by Countries (2015-2020)
Table 86. North America Antibody Drug Conjugate Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Antibody Drug Conjugate Revenue Market Share by Countries (2015-2020)
Table 88. Europe Antibody Drug Conjugate Sales by Countries (2015-2020) (K Units)
Table 89. Europe Antibody Drug Conjugate Sales Market Share by Countries (2015-2020)
Table 90. Europe Antibody Drug Conjugate Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Antibody Drug Conjugate Sales by Regions (2015-2020) (K Units)
Table 92. Asia-Pacific Antibody Drug Conjugate Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Antibody Drug Conjugate Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Antibody Drug Conjugate Sales by Countries (2015-2020) (K Units)
Table 95. South America Antibody Drug Conjugate Sales Market Share by Countries (2015-2020)
Table 96. South America Antibody Drug Conjugate Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Antibody Drug Conjugate Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Antibody Drug Conjugate Sales by Countries (2015-2020) (K Units)
Table 99. Middle East & Africa Antibody Drug Conjugate Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Antibody Drug Conjugate Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Antibody Drug Conjugate Revenue Market Share by Countries (2015-2020)
Table 102. Global Antibody Drug Conjugate Sales by Type (2015-2020) (K Units)
Table 103. Global Antibody Drug Conjugate Sales Share by Type (2015-2020)
Table 104. Global Antibody Drug Conjugate Revenue by Type (2015-2020) (USD Million)
Table 105. Global Antibody Drug Conjugate Revenue Share by Type (2015-2020)
Table 106. Global Antibody Drug Conjugate Sales by Application (2015-2020) (K Units)
Table 107. Global Antibody Drug Conjugate Sales Share by Application (2015-2020)
Table 108. Global Antibody Drug Conjugate Sales Forecast by Regions (2021-2025) (K Units)
Table 109. Global Antibody Drug Conjugate Market Share Forecast by Regions (2021-2025)
Table 110. Global Antibody Drug Conjugate Sales Forecast by Type (2021-2025) (K Units)
Table 111. Global Antibody Drug Conjugate Market Share Forecast by Type (2021-2025)
Table 112. Global Antibody Drug Conjugate Sales Forecast by Application (2021-2025)
Table 113. Global Antibody Drug Conjugate Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Antibody Drug Conjugate Picture
Figure 2. Global Sales Market Share of Antibody Drug Conjugate by Type in 2019
Figure 3. Adcetris Picture
Figure 4. Kadcyl Picture
Figure 5. Other Picture
Figure 6. Antibody Drug Conjugate Sales Market Share by Application in 2018
Figure 7. Hospital Picture
Figure 8. Pharmaceutical Company Picture
Figure 9. Research Institutions Picture
Figure 10. Global Antibody Drug Conjugate Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Antibody Drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Antibody Drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Antibody Drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Antibody Drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Antibody Drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Antibody Drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Antibody Drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Antibody Drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Antibody Drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Antibody Drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Antibody Drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Antibody Drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Antibody Drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Antibody Drug Conjugate Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Antibody Drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Antibody Drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Antibody Drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Antibody Drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Antibody Drug Conjugate Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Antibody Drug Conjugate Sales Market Share by Manufacturer in 2019
Figure 31. Global Antibody Drug Conjugate Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Antibody Drug Conjugate Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Antibody Drug Conjugate Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Antibody Drug Conjugate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Antibody Drug Conjugate Revenue Market Share by Regions (2015-2020)
Figure 38. Global Antibody Drug Conjugate Revenue Market Share by Regions in 2018
Figure 39. North America Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure 40. Europe Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure 42. South America Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Antibody Drug Conjugate Sales and Growth Rate (2015-2020)
Figure 44. North America Antibody Drug Conjugate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Antibody Drug Conjugate Sales Market Share by Countries (2015-2020)
Figure 46. North America Antibody Drug Conjugate Sales Market Share by Countries in 2018
Figure 47. North America Antibody Drug Conjugate Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Antibody Drug Conjugate Revenue Market Share by Countries in 2018
Figure 49. United States Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Antibody Drug Conjugate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Antibody Drug Conjugate Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Antibody Drug Conjugate Revenue Market Share by Countries in 2019
Figure 55. Germany Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Antibody Drug Conjugate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Antibody Drug Conjugate Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Antibody Drug Conjugate Revenue Market Share by Regions 2019
Figure 63. China Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Antibody Drug Conjugate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Antibody Drug Conjugate Sales Market Share by Countries in 2019
Figure 70. South America Antibody Drug Conjugate Revenue Market Share by Countries in 2019
Figure 71. Brazil Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Antibody Drug Conjugate Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Antibody Drug Conjugate Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Antibody Drug Conjugate Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Antibody Drug Conjugate Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Antibody Drug Conjugate Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Antibody Drug Conjugate Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Antibody Drug Conjugate Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Antibody Drug Conjugate Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Antibody Drug Conjugate Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Antibody Drug Conjugate Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Antibody Drug Conjugate Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Antibody Drug Conjugate Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Seattle Genetics/Takeda、Bayer HealthCare、Immunomedics、Roche、Millennium Pharmaceuticals、ImmunoGen、Heidelberg Pharma、Celldex Therapeutics、Pfizer、Mersana Therapeutics、Oxford BioTherapeutics、Takeda Pharmaceutical Company Limited、

★調査レポート[世界の抗体薬物複合体市場2020年:製造業者別、地域別、種類・用途別] (コード:GIR20DC0530)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の抗体薬物複合体市場2020年:製造業者別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆